 who underwent surveillance, it is
possible that their lower incidence of thrombosis may translate into a reduction in access-related costs and hospitalizations, as demonstrated in a reanalysis of a small study by
Dossabhoy et al80 and by a quality improvement project

conducted by Wijnen et al.81 In the latter study, flow
surveillance produced a 32.5% reduction in the overall cost
of access care. Savings occurred chiefly in the prost